New breast cancer drug may benefit younger women, too
(HealthDay)—Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Dec 6, 2017
0
1
(HealthDay)—Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Dec 6, 2017
0
1
Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators ...
Nov 8, 2017
0
119
(HealthDay)—For postmenopausal breast cancer patients receiving aromatase inhibitors, oral osteoporosis therapy (OPT) is associated with improved survival, according to a study published online May 2 in Cancer.
May 8, 2017
0
0
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy ...
Feb 2, 2017
0
0
(HealthDay)—Use of an aromatase inhibitor in combination with growth hormone seems effective for optimizing height in 11β-hydroxylase-deficient congenital adrenal hyperplasia (CAH), according to a case report published ...
Jan 27, 2017
0
1
The early-stage findings, from an international team led by Imperial College London and the European Institute of Oncology in Milan, reveal some breast tumours evolve to make their own 'fuel supply', rendering treatments ...
Jan 23, 2017
0
36
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether and what advantages drugs from the drug class of aromatase inhibitors offer compared with other breast cancer treatments or with ...
Dec 29, 2016
0
1
(HealthDay)—Women on breast cancer drugs called aromatase inhibitors may show signs of early blood vessel damage that could lead to heart disease, a small study suggests.
Dec 9, 2016
0
1
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special ...
Dec 9, 2016
0
3
Adding an aromatase inhibitor to presurgery treatment with docetaxel, carboplatin, trastuzumab (Herceptin), and pertuzumab (Perjeta) did not significantly increase or decrease the percentage of patients with hormone receptor ...
Dec 9, 2016
0
0